Ajanta Pharma Share Price
Mid Cap | Pharmaceuticals and health care | NSE: AJANTPHARM | BSE: 532331
₹2,485.25 -135.90 (-5.18 %)
Last Updated: 04 Apr 2025 03:59 PM
Overview
Open (₹) 2,635.80
High (₹) 2,647.60
Low (₹) 2,475.00
Prev. Close (₹) 2,621.15
Volume 1,23,175
VWAP (₹) 2,506.68
ROCE (%) 29.95
Industry P/E 44.73
TTM P/E 34.57
P/B Ratio 8.80
Market Cap (₹) Cr.31,043.78
Dividend Yield (%)2.05
EPS (₹) 64.77
ROE22.94%
Sales Growth (%) 12.45
Profit Growth (%)38.81
Day Range
2,647.602,647.60
52 Week Range
2,049.753,485.75
Historical Returns
Returns (6M)
-24.92 %
Returns (1Y)
13.92 %
Returns (3Y)
113.44 %
Returns (5Y)
178.16 %
Returns (6M)
-24.92 %
Returns (1Y)
13.92 %
Returns (3Y)
113.44 %
Returns (5Y)
178.16 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (41.14%) TTM EPS Growth
- Company with no debt
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 41.14% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Strong trend indicated by ADX above 25.
Technicals
Technical Rating
RSI 44.74
MFI 64.94
ATR 165.72
Commodity Channel Index -108.04
ROC125 -21.11
ROC21 -7.13
Williams %R -91.22
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 2,563.66 | 2,641.38 | 2,693.21 | 2,511.83 | 2,434.11 | 2,382.28 | 2,304.56 |
Week Ago | 2,656.30 | 2,706.10 | 2,747.25 | 2,615.15 | 2,565.35 | 2,524.20 | 2,474.40 |
Month Ago | 2,651.35 | 2,734.05 | 2,793.20 | 2,592.20 | 2,509.50 | 2,450.35 | 2,367.65 |
EMA & SMA
2485.25
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 2579.76
9 Day 2638.93
10 Day 2614.16
12 Day 2588.12
14 Day 2599.37
20 Day 2659.56
26 Day 2667.87
50 Day 2774.75
100 Day 2902.11
200 Day 2795.33
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
RAVI AGRAWAL TRUST | block | Sell | 22 Dec, 2022 | ₹1,160.10 | 16,38,887 | NSE |
AAYUSH AGRAWAL TRUST | block | Sell | 22 Dec, 2022 | ₹1,160.10 | 38,53,959 | NSE |
UTI MUTUAL FUND | block | Buy | 22 Dec, 2022 | ₹1,160.10 | 3,04,697 | NSE |
TEMPLETON GLOBAL INVESTMENT TRUST - TEMPLETON EMERGING MARKETS SMALL CAP FUND | block | Buy | 22 Dec, 2022 | ₹1,160.10 | 1,18,321 | NSE |
TEACHERS RETIREMENT SYSTEM OF THE STATE OF ILLINOIS ¿ GRANDEUR PEAK GLOBAL ADVISORS | block | Buy | 22 Dec, 2022 | ₹1,160.10 | 72,121 | NSE |
TATA AIA LIFE INSURANCE COMPANY LIMITED | block | Buy | 22 Dec, 2022 | ₹1,160.10 | 3,23,240 | NSE |
NIPPON INDIA MUTUAL FUND | block | Buy | 22 Dec, 2022 | ₹1,160.10 | 7,15,450 | NSE |
MIRAE ASSET MUTUAL FUND | block | Buy | 22 Dec, 2022 | ₹1,160.10 | 1,29,300 | NSE |
INDIA ACORN FUND LTD | block | Buy | 22 Dec, 2022 | ₹1,160.10 | 20,776 | NSE |
ICICI PRUDENTIAL MUTUAL FUND | block | Buy | 22 Dec, 2022 | ₹1,160.10 | 10,86,110 | NSE |
RAVI AGRAWAL TRUST | bulk | Sell | 22 Dec, 2022 | ₹1,160.10 | 16,38,887 | NSE |
AAYUSH AGRAWAL TRUST | bulk | Sell | 22 Dec, 2022 | ₹1,160.10 | 38,53,959 | NSE |
NIPPON INDIA MUTUAL FUND | bulk | Buy | 22 Dec, 2022 | ₹1,160.10 | 7,15,450 | NSE |
ICICI PRUDENTIAL MUTUAL FUND | bulk | Buy | 22 Dec, 2022 | ₹1,160.10 | 10,86,110 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
28 Feb, 2025 | VANDANA SHAILESH SINGH | Disposal | ₹2,722.45 | 548 | NSE |
31 Dec, 2024 | J K TRIPATHI | Disposal | ₹2,895.00 | 100 | NSE |
31 Dec, 2024 | J K TRIPATHI | Disposal | ₹3,000.00 | 100 | NSE |
31 Dec, 2024 | J K TRIPATHI | Disposal | ₹3,060.00 | 49 | NSE |
31 Dec, 2024 | J K TRIPATHI | Disposal | ₹3,100.00 | 51 | NSE |
31 Dec, 2024 | J K TRIPATHI | Disposal | ₹2,950.00 | 100 | NSE |
06 Sept, 2024 | SEEMA AGRAWAL | Disposal | ₹3,287.23 | 5,000 | NSE |
06 Sept, 2024 | ARVIND K AGRAW | Disposal | ₹3,293.62 | 6,000 | NSE |
06 Sept, 2024 | ARVIND K AGRAWAL | Acquisition | ₹2.00 | 1,000 | NSE |
04 Sept, 2024 | J K TRIPATHI | Disposal | ₹3,200.00 | 100 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
25 Oct, 2024 | Rs.28.0000 per share(1400%)First Interim Dividend | 06 Nov, 2024 | 06 Nov, 2024 |
25 Jan, 2024 | Rs.26.0000 per share(1300%)Second Interim Dividend | 08 Feb, 2024 | 08 Feb, 2024 |
25 Jul, 2023 | Rs.10.0000 per share(500%)First Interim Dividend | 04 Aug, 2023 | 04 Aug, 2023 |
10 May, 2022 | Bonus issue in the ratio of 1:2 of Rs. 2/-. | 22 Jun, 2022 | 23 Jun, 2022 |
Announcements
Date | Source | Detail |
---|---|---|
27 Mar, 2025 | NSE India | AJANTA PHARMA LIMITED has informed the Exchange about Closure of Trading Window |
27 Mar, 2025 | NSE India | Ajanta Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
20 Mar, 2025 | BSE India | PFA Intimation for Capacity Addition. |
20 Mar, 2025 | NSE India | Ajanta Pharma Limited has informed the Exchange about Capacity addition |
20 Feb, 2025 | NSE India | Ajanta Pharma Limited has informed the Exchange about Participation in Investor Conference |
20 Feb, 2025 | BSE India | PFA Intimation w.r.t Participation in Investor Conference. |
07 Feb, 2025 | NSE India | Ajanta Pharma Limited has informed the Exchange about Participation in Investor Conference |
07 Feb, 2025 | BSE India | PFA herewith Intimation of Participation in Investor Conference |
05 Feb, 2025 | NSE India | PFA Integrated Filing- Financials for the quarter ended 31st December 2024 |
05 Feb, 2025 | BSE India | PFA herewith Integrated Filing (Financials) |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 20 Jan, 2025 | 30 Jan, 2025 |
Quarterly Results | -- | 17 Oct, 2024 | 28 Oct, 2024 |
Quarterly Results | -- | 19 Jul, 2024 | 30 Jul, 2024 |
Audited Results & Buy Back of Shares | -- | 29 Apr, 2024 | 02 May, 2024 |
Quarterly Results & 2nd Interim Dividend | -- | 26 Jan, 2024 | 31 Jan, 2024 |
Quarterly Results | -- | 20 Oct, 2023 | 31 Oct, 2023 |
Quarterly Results | -- | 18 Jul, 2023 | 27 Jul, 2023 |
Audited Results | -- | 28 Apr, 2023 | 05 May, 2023 |
Buy Back of shares | -- | 10 Mar, 2023 | 10 Mar, 2023 |
Quarterly Results | -- | 24 Jan, 2023 | 01 Feb, 2023 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 66.26% | 66.21% | 66.11% | 70.34% | 70.34% |
Foreign Institutions + | 9.26% | 9.11% | 10.07% | 8.95% | 7.9% |
Domestic Institutions + | 17.02% | 16.67% | 15.82% | 12.14% | 11.71% |
Government | 0.01% | 0% | 0% | 0% | 0% |
Public | 7.45% | 8.01% | 8% | 8.57% | 10.05% |
Others | 0% | 0% | 0% | 0% | 0% |
About Ajanta Pharma
Ajanta Pharma is a Public Limited Listed company incorporated on 31/12/1979 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1979PLC022059 and registration number is 022059. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3971.12 Cr. and Equity Capital is Rs. 25.27 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1979
Managing Director
Mr. Yogesh M Agrawal
NSE Symbol
AJANTPHARM
Ajanta Pharma Management
Name | Designation |
---|---|
Mr. Mannalal B Agrawal | Chairman |
Mr. Madhusudan B Agrawal | Vice Chairman |
Mr. Yogesh M Agrawal | Managing Director |
Mr. Rajesh M Agrawal | Joint Managing Director |
Mr. K H Viswanathan | Independent Director |
Mr. Prabhakar R Dalal | Independent Director |
Dr. Anjana Grewal | Independent Director |
Mr. Chandrakant M Khetan | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Ajanta Pharma
What is the share price of Ajanta Pharma?
The share price of Ajanta Pharma on 04 Apr, 2025 is ₹ 2,485.25.
What is 52W high and 52W low share price of Ajanta Pharma?
The highest and lowest 52W share prices of Ajanta Pharma are ₹ 3485.750 and ₹ 2049.750
What is the market cap of Ajanta Pharma?
The market capitalization of Ajanta Pharma as of 04 Apr, 2025 is ₹ 31,043.78 Crores
What is the P/E ratio of Ajanta Pharma?
The current P/E ratio of Ajanta Pharma as of 04 Apr, 2025 is 44.73
What is the PB ratio of Ajanta Pharma?
The PB ratio of Ajanta Pharma as of 04 Apr, 2025 is 8.80
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)